Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could Long-Acting HIV shots save lives and money in thailand?

NCT ID NCT05774548

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether long-acting antiretroviral drugs for HIV prevention (PrEP) are effective and affordable for key populations in Thailand, including men who have sex with men and transgender women. Researchers will survey over 10,000 people about their preferences, analyze clinic data, and use computer models to estimate the impact and cost. The goal is to help decide if long-acting PrEP should be offered more widely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could show whether long-acting HIV prevention drugs are worth using widely in Thailand, helping to reduce new HIV infections.
What could go wrong
This is an observational and modeling study, not a drug trial. It cannot prove that long-acting PrEP works better than current options, and real-world results may differ from the models.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10,720 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2022

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Minimum age of 18 years * Individual assigned male at birth reporting sex with men in the past 12 months * Self-reported HIV-negative MSM and TGW who either report interest in PrEP use, current PrEP use, or past PrEP use * Permit audio recording during the interview and/or discussion. Exclusion Criteria: * Not willing to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CAREMAT

    RECRUITING

    Chiang Mai, 50200, Thailand

  • Mplus Foundation

    RECRUITING

    Chiang Mai, 50200, Thailand

  • Mplus Foundation

    RECRUITING

    Chiang Rai, 57000, Thailand

  • Mplus Foundation

    RECRUITING

    Phitsanulok, 65000, Thailand

  • Rainbow Sky Association of Thailand (RSAT)

    RECRUITING

    Bangkok, Bangkapi, 10240, Thailand

  • Rainbow Sky Association of Thailand (RSAT)

    RECRUITING

    Chon Buri, Changwat Chon Buri, 20000, Thailand

  • Rainbow Sky Association of Thailand (RSAT)

    RECRUITING

    Hat Yai, Changwat Songkhla, 90110, Thailand

  • Rainbow Sky Association of Thailand (RSAT)

    RECRUITING

    Ubon Ratchathani, 34000, Thailand

  • Tangerine Clinic

    RECRUITING

    Bangkok, Pathumwan, 10330, Thailand

  • The Service Workers In Group Foundation (SWING)

    RECRUITING

    Bangkok, Building 3, Patpong, Surawong Road, 10500, Thailand

  • The Service Workers In Group Foundation (SWING)

    RECRUITING

    Bang Lamung, Changwat Chon Buri, 20150, Thailand

  • The Service Workers In Group Foundation (SWING)

    RECRUITING

    Bangkok, Phay Thai, 10400, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.